Prevalence and prognostic implication of sarcopenia among patients with stage B heart failure

Prevalence and prognostic implication of sarcopenia among patients with stage B heart failure - PAPRIKA-HF

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043959

Enrollment

600

Registered

2021-06-01

Start date

2021-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatients received with echocardiography The participants who can walk by themselves (including the participants who can walk using a staff and so on)

Exclusion criteria

Exclusion criteria: The participants who refused to participate in the study Participants treated with permanent pacemaker implantation Participants with hemodialysis Participants with active malignant disease Participants underwent heart transplantation or those treated with ventricular assist device

Design outcomes

Primary

Measure	Time frame
Composite endpoint including all-cause death, hospitalization due to acute coronary syndrome or heart failure hospitalization	—

Secondary

Measure	Time frame
All-cause death Hospitalization due to acute coronary syndrome Heart failure hospitalization Prevalence of sarcopenia	—

Countries

Japan

Contacts

Public ContactKoichiro Matsumura

Kindai University Department of Cardiology

kmatsumura1980@yahoo.co.jp+81723660221

Outcome results